INS and diabetes mellitus: One of the mechanisms affecting the induction of the tumorigenesis process in diabetes is the increase in the bioavailability of the insulin-like growth factor-1 (IGF-1), which under standard conditions is responsible for lowering blood glucose levels and simultaneously diminishing insulin levels [83].